1α,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1α,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells
Mei-Ling Siu–Caldera(Women & Infants Hospital of Rhode Island), G. Satyanarayana Reddy(Women & Infants Hospital of Rhode Island), Anabela Santos-Moore(Roger Williams Medical Center), Surendra Sharma(Brown University), Jeffrey W. Clark(Massachusetts General Hospital), Yan Yun Liu(The University of Texas MD Anderson Cancer Center), Milan R. Uskoković(Nutrasource), Sara Peleg(The University of Texas MD Anderson Cancer Center)
The Journal of Steroid Biochemistry and Molecular Biology
December 1, 1996
Cited by 33
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2014|2k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers
|Journal of Clinical Oncology|2012|1.6k